Mead Johnson Nutrition Co. (MJN) Releases FY14 Earnings Guidance
Mead Johnson Nutrition Co. (NYSE:MJN) updated its FY14 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $3.50-3.62 for the period, compared to the Thomson Reuters consensus estimate of $3.67, AnalystRatings.NET reports.
Mead Johnson Nutrition Co. (NYSE:MJN) traded down 1.60% during mid-day trading on Friday, hitting $78.10. The stock had a trading volume of 1,474,595 shares. Mead Johnson Nutrition Co. has a 1-year low of $66.80 and a 1-year high of $86.87. The stock has a 50-day moving average of $82.53 and a 200-day moving average of $79.10. The company has a market cap of $15.775 billion and a P/E ratio of 25.61.
Mead Johnson Nutrition (NYSE:MJN) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.01. The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the previous year, the company posted $0.72 earnings per share. The company’s revenue for the quarter was up 8.0% on a year-over-year basis. On average, analysts predict that Mead Johnson Nutrition Co. will post $3.37 earnings per share for the current fiscal year.
A number of analysts have recently weighed in on MJN shares. Analysts at Socgen initiated coverage on shares of Mead Johnson Nutrition in a research note to investors on Friday. They set a buy rating on the stock. On a related note, analysts at Societe Generale initiated coverage on shares of Mead Johnson Nutrition in a research note to investors on Thursday. They set a buy rating on the stock. Finally, analysts at Deutsche Bank reiterated a buy rating on shares of Mead Johnson Nutrition in a research note to investors on Tuesday. They now have a $94.00 price target on the stock. Nine equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. Mead Johnson Nutrition has an average rating of Buy and a consensus price target of $85.53.
Mead Johnson Nutrition Company (NYSE:MJN) is a global pediatric nutrition company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.